BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 23814014)

  • 1. Carbenoxolone treatment ameliorated metabolic syndrome in WNIN/Ob obese rats, but induced severe fat loss and glucose intolerance in lean rats.
    Prasad Sakamuri SS; Sukapaka M; Prathipati VK; Nemani H; Putcha UK; Pothana S; Koppala SR; Ponday LR; Acharya V; Veetill GN; Ayyalasomayajula V
    PLoS One; 2012; 7(12):e50216. PubMed ID: 23284633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel fat depot-specific mechanisms underlie resistance to visceral obesity and inflammation in 11 β-hydroxysteroid dehydrogenase type 1-deficient mice.
    Wamil M; Battle JH; Turban S; Kipari T; Seguret D; de Sousa Peixoto R; Nelson YB; Nowakowska D; Ferenbach D; Ramage L; Chapman KE; Hughes J; Dunbar DR; Seckl JR; Morton NM
    Diabetes; 2011 Apr; 60(4):1158-67. PubMed ID: 21350084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UV-filter benzophenones suppress human, pig, rat, and mouse 11β-hydroxysteroid dehydrogenase 1: Structure-activity relationship and in silico docking analysis.
    Hao T; Zhao X; Ji Z; Xia M; Lu H; Sang J; Wang S; Li L; Ge RS; Zhu Q
    Comp Biochem Physiol C Toxicol Pharmacol; 2024 Jul; 281():109900. PubMed ID: 38518984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. JTT-654, an 11-beta hydroxysteroid dehydrogenase type 1 inhibitor, improves hypertension and diabetic kidney injury by suppressing angiotensinogen production.
    Heitaku S; Sasase T; Sotani T; Maki M; Kawai T; Morinaga H; Nishiu J
    J Pharmacol Sci; 2024 Apr; 154(4):246-255. PubMed ID: 38485342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogenated bisphenol A derivatives potently inhibit human and rat 11β-hydroxysteroid dehydrogenase 1: Structure-activity relationship and molecular docking.
    Wang H; Sang J; Ji Z; Yu Y; Wang S; Zhu Y; Li H; Wang Y; Ge RS
    Environ Toxicol; 2024 May; 39(5):2560-2571. PubMed ID: 38189224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Adrenergic Stimulation-Induced PVAT Dysfunction in Male Sex: A Role for 11β-Hydroxysteroid Dehydrogenase-1.
    Victorio JA; Barssotti L; Aprahamian T; Costa RG; Mousovich-Neto F; Oliveira HCF; Mori M; Rossoni LV; Davel AP
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38712392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visceral fat sympathectomy ameliorates systemic and local stress response related to chronic sleep restriction.
    Azuara-Alvarez LE; Díaz-Muñoz M; Báez Ruiz A; Saderi N; Ramírez-Plascencia OD; Cárdenas-Romero S; Flores-Sandoval O; Salgado-Delgado R
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2381-2392. PubMed ID: 38143435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis.
    Davidson CT; Miller E; Muir M; Dawson JC; Lee M; Aitken S; Serrels A; Webster SP; Homer NZM; Andrew R; Brunton VG; Hadoke PWF; Walker BR
    PLoS One; 2023; 18(3):e0255709. PubMed ID: 36940215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of 11β-hydroxysteroid dehydrogenase 1 in visceral adipose tissue and underexpression of endothelial nitric oxide synthase in the adrenal cortex of dogs with hyperadrenocorticism.
    Miceli DD; Abiuso AMB; Vidal PN; Gallelli MF; Pignataro OP; Castillo VA
    Open Vet J; 2018; 8(1):77-85. PubMed ID: 29721436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic alterations of 11beta-hydroxysteroid dehydrogenase 1 gene in the adipose tissue of patients with primary aldosteronism.
    Takeda Y; Demura M; Kometani M; Karashima S; Aono D; Konishi S; Horike SI; Meguro-Horike M; Yoneda T; Takeda Y
    Endocr J; 2024 Mar; 71(3):245-252. PubMed ID: 38143086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Hsd11b1 suppresses caloric-restriction-induced bone marrow adiposity in male but not female mice.
    Lovdel A; Suchacki K; Roberts F; Sulston RJ; Wallace RJ; Thomas BJ; Bell RMB; Pruñonosa Cervera I; Macpherson G; Morton N; Homer NZZM; Chapman KE; Cawthorn WP
    J Endocrinol; 2024 May; ():. PubMed ID: 38805506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterizing the Nonlinear Pharmacokinetics and Pharmacodynamics of BI 187004, an 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor, in Humans by a Target-Mediated Drug Disposition Model.
    Yuan X; An G
    J Clin Pharmacol; 2024 Apr; ():. PubMed ID: 38652112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Resveratrol Influence the Activity of 11β-Hydroxysteroid Dehydrogenase Type 1? A Combined In Silico and In Vivo Study.
    Novak J; Tseilikman VE; Tseilikman OB; Lazuko SS; Belyeva LE; Rahmani A; Fedotova J
    Pharmaceuticals (Basel); 2023 Feb; 16(2):. PubMed ID: 37259398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroendocrine-Immune Regulatory Network of
    Zhao Y; Tan DC; Peng B; Yang L; Zhang SY; Shi RP; Chong CM; Zhong ZF; Wang SP; Liang QL; Wang YT
    Molecules; 2022 Jun; 27(12):. PubMed ID: 35744822
    [No Abstract]   [Full Text] [Related]  

  • 15. Phytochemicals as Potential Epidrugs in Type 2 Diabetes Mellitus.
    Ramírez-Alarcón K; Victoriano M; Mardones L; Villagran M; Al-Harrasi A; Al-Rawahi A; Cruz-Martins N; Sharifi-Rad J; Martorell M
    Front Endocrinol (Lausanne); 2021; 12():656978. PubMed ID: 34140928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamus-pituitary-adrenal Axis in Glucolipid metabolic disorders.
    Lin Y; Zhang Z; Wang S; Cai J; Guo J
    Rev Endocr Metab Disord; 2020 Dec; 21(4):421-429. PubMed ID: 32889666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N; Kubota S; Kato I; Kobayashi Y
    J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N; Minamitani E; Yamaguchi Y; Kobayashi Y
    Steroids; 2011 Dec; 76(14):1546-53. PubMed ID: 21945397
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.